This inventor holds 2 USPTO granted patents. Top assignee: Otsuka Pharmaceutical Company, Limited. Active years: 1995-1997.
Company Filing History:
Years Active: 1995-1997
Title: Hitomi Iba: Innovator in Apoptosis Regulating Compositions
Introduction
Hitomi Iba is a prominent inventor based in Wakayama, Japan. She has made significant contributions to the field of biomedical research, particularly in the development of apoptosis regulating compositions. With a total of two patents to her name, her work focuses on innovative solutions for various health challenges.
Latest Patents
One of Hitomi Iba's latest patents involves apoptosis regulating compositions that comprise carbostyril derivatives and their salts. These compositions serve as active ingredients and are designed for use as anticancer agents, antiretrovirus agents, and therapeutic agents for autoimmune diseases, among other applications. The compositions also have potential in treating thrombocytopenia, Alzheimer's disease, liver diseases, and inhibiting cancer metastasis.
Career Highlights
Hitomi Iba is currently associated with Otsuka Pharmaceutical Company, Limited, where she continues to advance her research and development efforts. Her innovative work has positioned her as a key figure in the pharmaceutical industry, contributing to the development of effective therapeutic agents.
Collaborations
Throughout her career, Hitomi has collaborated with notable colleagues, including Satoru Nakai and Koutoku Aihara. These collaborations have further enhanced her research capabilities and have led to significant advancements in her field.
Conclusion
Hitomi Iba's contributions to the field of apoptosis regulating compositions highlight her role as an influential inventor in biomedical research. Her innovative approaches and collaborations continue to pave the way for new therapeutic solutions.